Tag: Drug

America’s AI Action Plan Boosts Pharmaceutical Innovation

Accelerating Pharmaceutical and Biopharmaceutical Innovation through America’s AI Action Plan America’s AI Action Plan, unveiled in July 2025, lays out a comprehensive strategy to propel...

Trump To Roll-Out 340B Drugs Discount Program in 2026

The Trump administration is going to pilot a voluntary program in 2026, wherein the pharmaceutical companies can offer rebates for certain drugs to hospitals...

AI in Alzheimer Drug Development to Enhances Clinical Trials

Scientists applied artificial intelligence (AI) to reanalyse a clinical trial for AI in Alzheimer Drug Development, identifying a group of patients who responded to...

Nipah Virus Vaccines Enter Clinical Trials in Bangladesh

Two Vaccines against the Nipah virus, a deadly bat-borne virus, are scheduled to begin human clinical trials in Bangladesh, while intriguing medication candidates have...

Optibrium secures multi-million-pound financing package from Shawbrook to accelerate business growth

Proceeds will accelerate Optibrium’s product development and expand the global reach of its computational chemistry and AI-driven discovery technology.  CAMBRIDGE, UK, 08 July 2025 – Optibrium,...

Pharmaceutical Stewardship in LMICs for AMR Control

Pharmaceutical Stewardship in LMICs: Key to Sustainable AMR Control Antimicrobial resistance (AMR) is one of the most challenging health issues of the 21st century, with...

Aptar CSP Technologies’ Dual-Active Material Science Technology Simultaneously Controls Moisture and Oxygen for Pharmaceutical Drugs and Medical Devices

Dual-active material science solution is ideal for sensitive formulations Auburn, AL, July 8, 2025 – Aptar CSP Technologies, part of AptarGroup, Inc. and a leader...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read